Viventia Biotech Inc. is a privately held biopharmaceutical company specializing in the discovery and development of a new generation of advanced monoclonal antibody products designed to offer safer, more beneficial therapies for those who suffer from cancer. Our lead product candidate Proxinium™ is in multiple clinical studies for the treatment of head and neck cancer. Vicinium™ is currently in an on-going clinical study for the treatment of bladder cancer.
Viventia Biotech Inc. is Etobicoke-based company (Ontario, Canada) with a phone number 4162911277. Our data show that the company is located at the address: 10 Four Seasons Place Suite 501 Toronto. The company has a web site: www.viventia.com.
Unfortunately сompany staff has not yet provided of company's activities, mission and detailed description.